|
Quotes & Info
|
| PG > SEC Filings for PG > Form 8-K on 15-Oct-2009 | All Recent SEC Filings |
15-Oct-2009
Regulation FD Disclosure
As disclosed in its most recent Form 10-K for the year ended June 30, 2009, The Procter & Gamble Company (the "Company") announced changes to its segment reporting structure that were effective July 1, 2009. Also, as disclosed in a Form 8-K dated August 24, 2009, the Company announced an agreement for the sale of its global pharmaceuticals business to Warner Chilcott. This Form 8-K provides pro forma historical total company and segment results for the three months ended September 30, 2008 reflecting the change in the reporting structure of the Company and the presentation of the Company's pharmaceuticals business as discontinued operations. This information in no way revises or restates the Consolidated Statement of Earnings, Consolidated Balance Sheet, Consolidated Statement of Shareholder's Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period.
Fiscal Year 2010 Changes to Global Business Unit (GBU) Structure Effective July 1, 2009, the Company implemented a number of changes to the organization structure of the Beauty GBU, which resulted in changes to the components of its reportable segment structure. Female blades and razors were formerly included in the Grooming reportable segment and are now included in the Beauty reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Beauty reportable segment to the Grooming reportable segment. In addition, the Beauty GBU was renamed the Beauty and Grooming GBU.
Presentation of the Global Pharmaceuticals Business as Discontinued Operations Separately, on August 24, 2009, the Company announced an agreement for the sale of its global pharmaceuticals business to Warner Chilcott which will be completed at a later date. The pharmaceuticals business has historically been part of the Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business will be presented as discontinued operations and, as such, will be excluded from continuing operations and from segment results.
The above changes will be reflected in the consolidated financial statements and segment reporting beginning in fiscal year 2010, starting with the Form 10-Q for the three months ended September 30, 2009. In advance of the Form 10-Q filing, this document provides pro forma consolidated earnings information and quarterly sales and profit information for the affected segments for the three months ended September 30, 2008.
CONSOLIDATED EARNINGS INFORMATION
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts)
Consolidated Earnings Information
Three Months Ended
September 30, 2008
As
Reported Pro forma
NET SALES $ 21,582 $ 20,983
COST OF PRODUCTS SOLD 10,620 10,558
GROSS MARGIN 10,962 10,425
SELLING, GENERAL & ADMINISTRATIVE EXPENSE 6,393 6,039
OPERATING INCOME 4,569 4,386
TOTAL INTEREST EXPENSE 339 339
OTHER NON-OPERATING INCOME, NET 336 280
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 4,566 4,327
INCOME TAXES 1,291 1,212
NET EARNINGS FROM CONTINUING OPERATIONS 3,275 3,115
NET EARNINGS FROM DISCONTINUED OPERATIONS 73 233
NET EARNINGS 3,348 3,348
EFFECTIVE TAX RATE FROM CONTINUING OPERATIONS 28.3 % 28.0 %
PER COMMON SHARE:
BASIC NET EARNINGS - CONTINUING OPERATIONS $ 1.07 $ 1.02
BASIC NET EARNINGS - DISCONTINUED OPERATIONS $ 0.03 $ 0.08
BASIC NET EARNINGS $ 1.10 $ 1.10
DILUTED NET EARNINGS - CONTINUING OPERATIONS $ 1.01 $ 0.96
DILUTED NET EARNINGS - DISCONTINUED OPERATIONS $ 0.02 $ 0.07
DILUTED NET EARNINGS $ 1.03 $ 1.03
DIVIDENDS $ 0.40 $ 0.40
AVERAGE DILUTED SHARES OUTSTANDING 3,239.5 3,239.5
|
SEGMENT REPORTING INFORMATION
Three Months Ended September 30, 2008
As Reported Pro forma
Earnings From Net Earnings Earnings From Net Earnings
Continuing From Continuing From
Net Operations Before Continuing Net Operations Before Continuing
Sales Income Taxes Operations Sales Income Taxes Operations
Beauty and
Grooming GBU
Beauty $5,129 $ 983 $ 753 $5,181 $ 1,018 $ 788
Grooming 2,142 645 478 2,090 610 443
Health and
Well-Being GBU
Health Care 3,701 990 657 3,101 757 503
Snacks and Pet
Care 807 90 55 807 90 55
Household Care GBU
Fabric Care and
Home Care 6,483 1,261 826 6,483 1,261 826
Baby Care and
Family Care 3,772 807 514 3,772 807 514
Total Business
Segments 22,034 4,776 3,283 21,434 4,543 3,129
Corporate (452) (210) (8) (451) (216) (14)
Total Company $21,582 $ 4,566 $ 3,275 $20,983 $ 4,327 $ 3,115
|
This 8-K is furnished pursuant to Item 7.01 "Regulation FD Disclosure".
|
|